Asset Class Outlook – Equity

Equities are expected to deliver ~15% CAGR over the coming years, supported by India’s catch-up growth phase and favourable policy environment.

Pharma Sector: Good Buying Opportunity!

After a prolonged downturn driven by US generics pressure and regulatory challenges, the Indian pharma sector appears to be at an inflection point with improving fundamentals, currency tailwinds, and stabilizing US operations.